These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 855758)

  • 1. Dose-response relationship of a uricosuric diuretic.
    Emmerson BT; Thompson L; Mitchell K
    Adv Exp Med Biol; 1977; 76B():320-7. PubMed ID: 855758
    [No Abstract]   [Full Text] [Related]  

  • 2. Comparison of oral indacrinone with furosemide.
    Irvin JD; Vlasses PH; Huber PB; Ferguson RK; Schrogie JJ; Davies RO
    Clin Pharmacol Ther; 1980 Sep; 28(3):376-83. PubMed ID: 6996896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Saluretic and uricosuric effects of (6, 7-dichloro-2-methyl=1-oxo-2-phenyl-5-indanyloxy) acetic acid (MK-196) in the chimpanzee.
    Fanelli GM; Bohn DL; Scriabine A; Beyer KH
    J Pharmacol Exp Ther; 1977 Feb; 200(2):402-12. PubMed ID: 14250
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Indacrinone: natriuretic and uricosuric effects of various ratios of its enantiomers in healthy men.
    Vlasses PH; Rotmensch HH; Swanson BN; Irvin JD; Johnson CL; Ferguson RK
    Pharmacotherapy; 1984; 4(5):272-7. PubMed ID: 6504708
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the mechanism and characteristics of action of a uricosuric diuretic, indacrinone (MK-196).
    Brooks BA; Blair EM; Finch R; Lant AF
    Br J Clin Pharmacol; 1980 Sep; 10(3):249-58. PubMed ID: 7437242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new diuretic that does not reduce renal handling of uric acid in rats, S-8666.
    Yonetani Y; Iwaki K; Ishii M; Harada H
    Jpn J Pharmacol; 1987 Apr; 43(4):399-405. PubMed ID: 3613286
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhancement of uricosuric properties of indacrinone by manipulation of the enantiomer ratio.
    Tobert JA; Cirillo VJ; Hitzenberger G; James I; Pryor J; Cook T; Buntinx A; Holmes IB; Lutterbeck PM
    Clin Pharmacol Ther; 1981 Mar; 29(3):344-50. PubMed ID: 7471605
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of enantiomers and (-) p-OH metabolite of indacrinone.
    Vlasses PH; Irvin JD; Huber PB; Lee RB; Ferguson RK; Schrogie JJ; Zacchei AG; Davies RO; Abrams WB
    Clin Pharmacol Ther; 1981 Jun; 29(6):798-807. PubMed ID: 7226712
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enantiomers of indacrinone: a new approach to producing an isouricemic diuretic.
    Blaine EH; Fanelli GM; Irvin JD; Tobert JA; Davies RO
    Clin Exp Hypertens A; 1982; 4(1-2):161-76. PubMed ID: 7074983
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Indacrinone: modification of diuretic, uricosuric, and kaliuretic actions by amiloride.
    Ravenscroft PJ; Hall GR; Ahokas JT; Emmerson BT; Tobert JA
    Clin Pharmacol Ther; 1980 Jul; 28(1):45-51. PubMed ID: 7389253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of furosemide, piretanide and MK-196 on volume sensitive solute transport in fish erythrocytes.
    Wolowyk MW; Fincham DA; Young JD
    Proc West Pharmacol Soc; 1989; 32():309-11. PubMed ID: 2780610
    [No Abstract]   [Full Text] [Related]  

  • 12. (1-oxo-2-substituted-5-indanyloxy)acetic acids, a new class of potent renal agents possessing both uricosuric and saluretic activity. A reexamination of the role of sulfhydryl binding in the mode of action of acylphenoxyacetic acidsaluretics.
    Cragoe EJ; Schultz EM; Schneeberg JD; Stokker GE; Woltersdorf OW; Fanelli GM; Watson LS
    J Med Chem; 1975 Feb; 18(2):225-8. PubMed ID: 1120997
    [No Abstract]   [Full Text] [Related]  

  • 13. Diuretic effect of butoxymethylen furosemide (FFBU) in healthy subjects: a preliminary study.
    Licht A; Levy M; Schindel L; Eliakim M
    Curr Ther Res Clin Exp; 1973 Oct; 15(10):713-26. PubMed ID: 4201316
    [No Abstract]   [Full Text] [Related]  

  • 14. Antihypertensive and biochemical effects of indacrinone enantiomers.
    Jain AK; Michael R; Ryan JR; McMahon FG
    Pharmacotherapy; 1984; 4(5):278-83. PubMed ID: 6504709
    [TBL] [Abstract][Full Text] [Related]  

  • 15. (Acylaryloxy)acetic acid diuretics. 5. [(2-Alkyl- and 2,2-disubstituted-1,3-dioxo-5-indanyl)oxy]acetic acids.
    Woltersdorf OW; deSolms SJ; Stokker GE; Cragoe EJ
    J Med Chem; 1984 Jul; 27(7):840-5. PubMed ID: 6737427
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Renal actions of a uricosuric diuretic, racemic indacrinone, in man: comparison with ethacrynic acid and hydrochlorothiazide.
    Brooks BA; Lant AF; McNabb WR; Noormohamed FH
    Br J Clin Pharmacol; 1984 May; 17(5):497-512. PubMed ID: 6428442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of ticrynafen in the rat.
    Minor S; Taylor K; Knight TF; Senekjian HO; Weinman EJ
    Res Commun Chem Pathol Pharmacol; 1979 Jul; 25(1):53-63. PubMed ID: 451359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bumetanide and frusemide: a comparison of dose-response curves in healthy men.
    Ramsay LE; McInnes GT; Hettiarachchi J; Shelton J; Scott P
    Br J Clin Pharmacol; 1978 Mar; 5(3):243-7. PubMed ID: 656269
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Uricosuric diuretics.
    Emmerson BT
    Kidney Int; 1980 Nov; 18(5):677-85. PubMed ID: 7463959
    [No Abstract]   [Full Text] [Related]  

  • 20. Ticrynafen, a uricosuric antihypertensive diuretic.
    Stote RM; Dubb JW; Familiar RG; Alexander F
    Clin Pharmacol Ther; 1978 Apr; 23(4):456-60. PubMed ID: 630794
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.